Clinical Trials Browser

Phase 3 × Withdrawn × Cytarabine × Clear all

NCT01067274 2015-12-30

ALFA-0703

Phase 3 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00411281 2015-09-30

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Phase 3 Withdrawn

MyeloidOther hematologic neoplasm

Myeloproliferative Syndrome, Transient, Leukemia, Leukemia, Myeloid, Acute